Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Staged hybrid approach using proximal thoracic endovascular aneurysm repair and distal open repair for the treatment of extensive thoracoabdominal aortic aneurysms.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Elsevier Country of Publication: United States NLM ID: 8407742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6809 (Electronic) Linking ISSN: 07415214 NLM ISO Abbreviation: J Vasc Surg Subsets: MEDLINE
- Publication Information:
Publication: <2008-> : New York, NY : Elsevier
Original Publication: St. Louis, Mo. : Mosby, [c1984-
- Subject Terms:
- Abstract:
Objective: Repair of patients with extent I and II thoracoabdominal aortic aneurysms (TAAAs) is associated with significant morbidity and mortality, whereas repair of more distal extent III and IV TAAAs has a lower risk of paraplegia and death. Therefore, we describe an approach using thoracic endovascular aneurysm repair (TEVAR) as the index operation to convert extent I and II TAAAs to extent III and IV TAAAs amenable to subsequent open aortic repair to minimize patient risk.
Methods: Between July 2007 and March 2012, 10 staged hybrid operations were performed to treat one extent I and nine extent II TAAAs. Aortic aneurysm pathology included five chronic type B dissections, three acute type B dissections, and two penetrating aortic ulcers. Initially, the proximal descending thoracic aorta was repaired with TEVAR for coverage of the most proximal fenestration or penetrating ulcer, with seven elective and three emergent repairs. Interval open distal aortic replacement was performed in a short-term planned setting or for progressive dilation of the distal aortic segment. In the open repair, the proximal end of the graft was sewn directly to the distal end of the TEVAR and outer wall of the aorta.
Results: Average patient age was 48 years, and 60% were men. Risk factors included hypertension (80%), current tobacco use (50%), and Marfan syndrome (30%). Complications after TEVAR included type IA (n=1) and type II (n=3) endoleaks, pleural effusions (n=3), and acute kidney injury (n=1). Three patients required endovascular reinterventions. In patients with dissection, persistent filling of the false lumen was common and associated with distal thoracic aortic dilation. Complications of open repair included acute kidney injury in two patients, but no cardiac, pulmonary, or neurologic morbidity. Median time between TEVAR and open repair was 14 weeks. Most importantly, no deaths or neurologic deficits occurred after either procedure during a median follow-up of 35 weeks.
Conclusions: A staged hybrid approach to extensive TAAAs combining proximal TEVAR, followed by interval open distal TAAA repair, is safe and appears to be an effective alternative to traditional open repair. This approach may decrease the significant morbidity associated with single-stage open extent I and II TAAA repairs and may be applicable to multiple TAAA etiologies.
(Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.)
- References:
J Vasc Surg. 2006 Feb;43(2):217-22; discussion 223. (PMID: 16476589)
Ann Thorac Surg. 2001 Apr;71(4):1233-8. (PMID: 11308166)
Vascular. 2010 Nov-Dec;18(6):336-43. (PMID: 20979921)
J Vasc Surg. 2008 May;47(5):912-8. (PMID: 18353605)
J Vasc Surg. 1999 Sep;30(3):555-60. (PMID: 10477650)
Ann Thorac Surg. 2010 May;89(5):1475-81. (PMID: 20417763)
J Endovasc Ther. 2006 Aug;13(4):481-9. (PMID: 16928162)
J Thorac Cardiovasc Surg. 2010 Jun;139(6):1464-72. (PMID: 20494193)
Ann Surg. 2002 Oct;236(4):471-9; discussion 479. (PMID: 12368676)
J Thorac Cardiovasc Surg. 2010 Nov;140(5):1001-10. (PMID: 20951252)
Crit Care. 2004 Aug;8(4):R204-12. (PMID: 15312219)
Ann Thorac Surg. 2000 Feb;69(2):409-14. (PMID: 10735672)
J Vasc Surg. 1986 Apr;3(4):578-82. (PMID: 3959256)
Perspect Vasc Surg Endovasc Ther. 2012 Mar;24(1):5-13. (PMID: 22316552)
J Vasc Surg. 2003 Jun;37(6):1169-74. (PMID: 12764260)
Ann Thorac Surg. 2011 Jul;92(1):138-46; discussion 146. (PMID: 21718839)
Ann Thorac Surg. 2010 Sep;90(3):722-9. (PMID: 20732484)
J Vasc Surg. 1986 Mar;3(3):389-404. (PMID: 3951025)
Ann Intern Med. 2003 Jul 15;139(2):137-47. (PMID: 12859163)
Ann Thorac Surg. 1997 Sep;64(3):639-50. (PMID: 9307451)
Ann Thorac Surg. 2002 Apr;73(4):1107-15; discussion 1115-6. (PMID: 11996250)
Ann Thorac Surg. 2007 Feb;83(2):S862-4; discussion S890-2. (PMID: 17257942)
Ann Thorac Surg. 2007 Feb;83(2):S856-61; discussion S890-2. (PMID: 17257941)
- Grant Information:
T32 HL007849 United States HL NHLBI NIH HHS
- Publication Date:
Date Created: 20120727 Date Completed: 20130311 Latest Revision: 20221207
- Publication Date:
20231215
- Accession Number:
PMC3508078
- Accession Number:
10.1016/j.jvs.2012.05.091
- Accession Number:
22832268
No Comments.